Cargando…
1594. Evaluating Clinical Outcomes of an Alternative Cefepime Dosing Regimen as Empiric Antibiotic Therapy in Hospitalized Adults with Febrile Neutropenia
BACKGROUND: A cefepime dosing regimen of 1 g every 6 hours (1 g Q6h) has shown to provide similar exposure above the target minimum inhibitory concentration than the higher FDA-approved regimen of 2 g Q8h for febrile neutropenia. We hypothesize clinical outcomes among patients receiving either dosin...
Autores principales: | Haiduc, Manuela, Bremmer, Derek, Patel, Monank, Walsh, Thomas, Moffa, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253577/ http://dx.doi.org/10.1093/ofid/ofy210.1422 |
Ejemplares similares
-
The Dose-Dependent Efficacy of Cefepime in the Empiric Management of Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Andreatos, Nikolaos, et al.
Publicado: (2017) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018) -
Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
por: Giurici, Nagua, et al.
Publicado: (2011) -
Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021) -
1087. Fluoroquinolone Prophylaxis vs. No Bacterial Prophylaxis in Hospitalized Neutropenic Patients Undergoing Induction Chemotherapy for Acute Myeloid Leukemia
por: Buchanan, Carley, et al.
Publicado: (2019)